GI-30N

N/A

Report date: 2023/01/07 12:17:32
NME

Base Information

Drug NameGI-30N
Drug Alias NameGI-30N
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsFibrosisHypersensitivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGI Innovation Inc
China Registration ClassN/A

Develop Information

Active CompaniesGI Innovation Inc
Inactive CompaniesN/A
Active IndicationsFibrosisHypersensitivity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A